Influence of Metabolic Dysfunction-Associated Steatotic Liver Disease on Pattern and Management of Acute Coronary Syndrome

January 1, 2026Saudi Medical JournalOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to investigate how metabolic dysfunction-associated steatotic liver disease (MASLD) affects acute coronary syndrome patterns and treatment.
Analyzed occurrence of STEMI and NSTEMI in patients with MASLD.
Examined incidence of coronary artery occlusion in individuals with hepatic fibrosis.
Evaluated need for cardiac interventions among MASLD patients.
Higher frequency of STEMI and NSTEMI was noted among MASLD patients.
MASLD patients with hepatic fibrosis experienced more occludable coronary arteries.
Increased cardiac interventions were required for this population.

Observational analysis reveals increased coronary artery occlusion in metabolic dysfunction patients, suggesting enhanced cardiac intervention needs.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Abdulkhalik et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share